Literature DB >> 2138938

Cells and mediators which participate in immunoglobulin synthesis by human mononuclear cells. II. The mechanism of null cell participation in immunoglobulin synthesis and secretion by B cells.

M Richter1, S Taylor, S Macphail, C A Jodouin.   

Abstract

Immunoglobulins were synthesized and secreted by human B cells cultured with T cells with receptors for FcM (TM) helper cells, monocytes, null cells and PWM for 7 days. Immunoglobulin synthesis did not take place if the null cells were omitted from the cultures irrespective of the duration of the culture period. Null cells incorporated into the cultures at only 25% of their optimal concentration did not affect immunoglobulin synthesis markedly by the cultured B cells. However, the number of B cells in the culture could not be diluted without an accompanying marked reduction in immunoglobulin synthesis. The B cells synthesized and secreted significant quantities of immunoglobulin even when the null cells were added as late as day 6 of the 7-day culture whereas no or very little immunoglobulin was synthesized if the B cells were not present from the beginning of the 7-day culture. It was demonstrated that cultured null cells do not transform into B cells and do not attain their immunoglobulin-synthesizing function. Furthermore, cultured B cells do not transform into null cells and do not attain their helper function. The null cells can also be distinguished from the B cells on the basis of cell-surface markers, receptors, and blastogenic responsiveness to phytomitogens. It is concluded that (i) the human circulating B cells require the null cells, in addition to the TM cells, monocytes and PWM, in culture in order to synthesize and secrete immunoglobulin; (ii) the null cell signal that stimulates immunoglobulin synthesis and secretion by the B cells is probably the last signal following the TM helper cell, monocyte and PWM signals received by the B cells; and (iii) the null cells and the B cells constitute distinct lineages of cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138938      PMCID: PMC1535216          DOI: 10.1111/j.1365-2249.1990.tb06451.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

Review 1.  Functional analysis of murine and human B lymphocyte subsets.

Authors:  G Janossy; M Greaves
Journal:  Transplant Rev       Date:  1975

2.  Ontogeny of B-lymphocyte differentiation induced by pokeweed mitogen.

Authors:  L Y Wu; A Blanco; M D Cooper; A R Lawton
Journal:  Clin Immunol Immunopathol       Date:  1976-03

3.  Antibody in the induction and inhibition of lymphocyte cytotoxicity.

Authors:  I C MacLennan
Journal:  Transplant Rev       Date:  1972

4.  Human lymphocytes with receptors for IgG. A population of cells distinct from T- and B-lymphocytes.

Authors:  S S Froland; F Wisloff; T E Michaelsen
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

5.  Membrane-bound immunoglobulin (Ig) and in vitro production of Ig by lymphoid cells from patients with primary immunodeficiencies.

Authors:  F Aiuti; L Fontana; R A Gatti
Journal:  Scand J Immunol       Date:  1973       Impact factor: 3.487

6.  Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.

Authors:  P Perlmann; H Perlmann; H Wigzell
Journal:  Transplant Rev       Date:  1972

7.  Inhibition of antibody-dependent human lymphocyte-mediated cytotoxicity by immunoglobulin classes, IgG subclasses, and IgG fragments.

Authors:  F Wisloff; T E Michaelsen; S S Froland
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

8.  Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin.

Authors:  D A Horwitz; P I Lobo
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Identification of two populations of immunoglobulin-bearing lymphocytes in man.

Authors:  P I Lobo; F B Westervelt; D A Horwitz
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

10.  Differentiation capacity of cultured B lymphocytes from immunodeficient patients.

Authors:  L Y Wu; A R Lawton; M D Cooper
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.